C
Cytomx Therapeutics (CTMX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Cytomx Therapeutics (CTMX)
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeuti... Read more
- USD2.50
- USD2.52
- USD2.44
- USD3.10
- -5.70%
- 148M
- 755.78k
- 2.83M
- 354M
- 0.40
- 92.30%
Stock News
yesterday
Here are the 2 big things we're watching in the stock market in the week ahead
CNBC
yesterday
OPEC+ to boost oil production even more than expected in August
MarketWatch
yesterday
Nations Chase US Trade Deals as Bessent Hints at Longer Deadline
Yahoo
yesterday
S&P 500: This Is Unusual, Week Starting 7th July (Technical Analysis)
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
